Cynosure Inc

Cynosure Inc. of Westford, Mass., has announced that the FDA has cleared its Cellulaze cellulite laser workstation for commercial distribution. The workstation provides a minimally invasive solution for reducing cellulite in just one treatment by restoring the normal structure of the skin and underlying connective tissue. Clinical data has demonstrated that the treatment can increase the thickness of the skin by 25 percent and elasticity by 29 percent at one year.





LATEST NEWS

• 3D Holography Integrated Glasses Could Unlock Mixed Reality
  May 2, 2024
• Generative AI Achieves Superresolution with Minimal Tuning
  May 2, 2024
• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024
• Machine Learning Pushes High-Power Lasing Limits
  May 1, 2024
• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024